Active Ingredient(s): Tralokinumab
FDA Approved: * December 27, 2021
Pharm Company: * LEO PHARMA AS
Category: Skin Care

Tralokinumab sold under the brand name Adtralza among others, is a human monoclonal antibody used for the treatment of atopic dermatitis.[1][3] Tralokinumab targets the cytokine interleukin 13.[5] The most common side effects include upper respiratory tract infections (colds and other infections of the nose and throat), reactions at the injection site, and redness and discomfort in the eye.[3] Tralokinumab was approved for medica... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Adbry 150 mg/ml Subcutaneous Injection, Solution
NDC: 50222-346
Leo Pharma Inc.

Related Brands

Drugs with the same active ingredients